^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Combotox (Imtox19/Imtox22)

i
Other names: Imtox19/Imtox22, deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins
Associations
Company:
Abiogen, Montefiore Medical Center, National Cancer Institute
Drug class:
CD19 inhibitor, Protein synthesis inhibitor, CD22 inhibitor
Related drugs:
Associations
over3years
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov)
P1, N=10, Completed, Albert Einstein College of Medicine | Recruiting --> Completed | N=20 --> 10
Trial completion • Enrollment change
|
CD19 (CD19 Molecule) • CD22 (CD22 Molecule)
|
CD19 expression
|
Combotox (Imtox19/Imtox22)